Cambridge Cognition - Capital Network: Paving the Way for Improved Mental Health Testing
Cambridge Cognition ("CamCog") (COG.LON) is an innovative healthcare technology company, focused on the development and commercialisation of computer-based cognitive assessment tests.
To conclude we would highlight how CamCog's work on the integration of cognitive monitoring software into wearable technology could lead to the development of new applications, such as facial and voice recognition mobile apps.
These kinds of products would in our view elicit a strong interest into CamCog's technology not just from players in the pharmaceutical space but also from healthcare providers and technology companies who are increasingly looking at new opportunities created by the digitalisation of healthcare.
Quick facts: Cambridge Cognition Holdings PLC
Price: 22 GBX
Market Cap: £5.32 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE
LEGAL NOTICE – IMPORTANT – PLEASE READ:
Proactive Research is a trading name of Proactive Investors Limited which is regulated and authorised by the Financial Conduct Authority (FCA) under firm registration...FOR OUR FULL DISCLAIMER CLICK HERE